Latham & Watkins
Julie Scallen
- Deals
- 4
- Latest
- Sep 2026
- Most deals in
- Medtech
Firm
- Latham & Watkins Law firm · 2026 · 4 deals
Often works with
- Eliot Choy 3 deals together
- Heather Deixler 3 deals together
- Betty Pang 3 deals together
- Chad Jennings 3 deals together
- Cherrie Wang 2 deals together
- Hans Brigham 2 deals together
- Katharine Moir 2 deals together
- Josh Friedman 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Sep 2026 | ITM Isotope Technologies Munich SE | – | Telix Pharmaceuticals | Merger | Legal adviser to ITM Isotope Technologies Munich SE | Announced | 2,350.0 | Healthcare+1 | Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger |
| May 2026 | SPR Therapeutics | – | Medtronic | Acquisition | Legal adviser to SPR (target) | Announced | 650.0 | Medtech | Medtronic acquisition of SPR Therapeutics |
| Mar 2026 | Scientia Vascular | – | Medtronic | Acquisition | Legal adviser to Scientia Vascular (target) | Announced | 550.0 | Medtech+1 | Medtronic acquisition of Scientia Vascular |
| Jan 2026 | Valencia Technologies | – | Boston Scientific | Acquisition | Legal adviser to Boston Scientific (acquirer) | Announced | – | Medtech | Boston Scientific acquisition of Valencia Technologies |
Deals where Julie Scallen is named on the firm's deal team, by the firm or the press.